Roger M. Lyons, MD, Discusses 10-Year Review of MDS Patient Data From the Community Oncology Setting
Evidence-Based Oncology™️ spoke with Lyons about the creation of this real-world data set and the pros and cons of different treatments for MDS.
Disparities in Multiple Myeloma: Quality Improvement Initiative Reveals Gaps Between Oncology Providers, Patients in Views of Costs, Risk of Treatments
An interview with Joseph R. Mikhael, MD, MEd, on findings from a Quality Improvement initiative presented during the 64th American Society of Hematology Annual Meeting and Exposition in New Orleans, Louisiana. Mikhael is a professor in the Applied Cancer Research and Drug Discovery Division at the Translational Genomics Research Institute, an affiliate of City of Hope Cancer Center, in Phoenix, Arizona.
